[Alnylam Pharmaceuticals](https://www.alnylam.com/about-alnylam)

May 29, 2026

Up to $250,000 per proposal; multiple awards possible; funding may be less than requested.

Supports independent educational initiatives to advance clinical decision-making and patient care in transthyretin-mediated amyloidosis (ATTR-CM).

Only organizations (not individuals or practice groups) are eligible; CME providers must be ACCME-accredited.

--- ## Description This grant opportunity from Alnylam Pharmaceuticals aims to support innovative, independent educational projects that address gaps in the screening, diagnosis, monitoring, and management of transthyretin-mediated amyloidosis (ATTR-CM). The primary focus is on equipping clinicians with actionable information and practical tools to improve real-world clinical decision-making and patient outcomes. Funded activities should be evidence-based, fair, and balanced, and designed for practical application in routine healthcare settings. Proposals may target U.S. and/or global audiences, with particular emphasis on specialists such as cardiologists and clinical pharmacists involved in ATTR-CM management. --- ## Due Dates - May 29, 2026: Submission deadline for RFP ALNY-RFP-TTR-13 (Advancing Clinical Decision-Making in ATTR-CM) --- ## Funding Amount - Individual proposals may be awarded up to $250,000 USD. - Multiple proposals may be funded (e.g., for different congresses or venues). - The actual amount awarded may be less than the amount requested. - Applicants are encouraged to seek multiple sources of funding, including registration fees or other grants. --- ## Eligibility - Eligible applicants: Professional associations, patient advocacy organizations, healthcare institutions, medical education companies, and other organizations committed to healthcare improvement. - Individuals, practice groups, HCP-owned clinics, managed care organizations, and pharmacy benefit managers are **not** eligible. - For CME activities, the applicant must be an ACCME-accredited provider; the accredited provider must submit the request. - All applicants must be able to provide valid, government-issued proof of tax status. - Activities must be compliant with all relevant laws and regulations. --- ## Application Process - Submit proposals electronically through the [Alnylam Grants Portal](https://alnylam-grants.steeprockinc.com) or via the [Grants and Giving page](https://www.alnylam.com/about-alnylam/grants-and-giving). - Submission must be in English and at least 45 days prior to the activity start date. - Required proposal components include: - Comprehensive gap analysis/needs assessment - Description of target audience and recruitment strategies - Clearly defined learning objectives - Overview of content accuracy and educational design - Faculty qualifications and recruitment plan - Evaluation and outcomes reporting methods - Detailed budget and allocation of funds - Proof of accreditation (for CME activities) - Conflict of interest resolution plan - Disclosure and sustainability plans - Honoraria and reimbursement policy - Project timeline - All proposals are reviewed by the Alnylam Grants and Giving Office; additional information may be requested. - Notification of decision will be sent by email. - For CME and non-CME grants, reconciliation is required within 90 days of program end. --- ## Additional Information - Educational activities should be grounded in peer-reviewed evidence and designed for practical clinical application. - Proposals may address congress symposia, digital CME platforms, regional or global live programs, and should consider region-specific channels. - Grant funds cannot be used for meals for attendee HCPs. - Alnylam may fund discrete events within a multi-venue proposal. - All awarded grants require execution of a formal agreement. --- ## External Links - [Alnylam Grants and Giving – Program Overview](https://www.alnylam.com/about-alnylam/grants-and-giving) - [RFP ALNY-RFP-TTR-13: Advancing Clinical Decision-Making in ATTR-CM (PDF)](https://www.alnylam.com/sites/default/files/pdfs/ALNY-RFP-TTR-13%20Advancing%20Clinical%20Decision-Making%20in%20ATTR-CM.pdf) - [Alnylam Grants Submission Portal](https://alnylam-grants.steeprockinc.com) --- ## Contact Information | Purpose | Contact | |---------------------------|---------------------------------------------------------| | General/RFP Questions | [grants@alnylam.com](mailto:grants@alnylam.com) | | Funder Website | [Alnylam Pharmaceuticals](https://www.alnylam.com/about-alnylam) |

Grants and Giving

Sign in to see full grant listing